Cargando…
Therapeutic targeting of “undruggable” MYC
c-MYC controls global gene expression and regulates cell proliferation, cell differentiation, cell cycle, metabolism and apoptosis. According to some estimates, MYC is dysregulated in ≈70% of human cancers and strong evidence implicates aberrantly expressed MYC in both tumor initiation and maintenan...
Autores principales: | Llombart, Victor, Mansour, Marc R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713111/ https://www.ncbi.nlm.nih.gov/pubmed/34942444 http://dx.doi.org/10.1016/j.ebiom.2021.103756 |
Ejemplares similares
-
Drugging the Undruggable: Advances on RAS Targeting in Cancer
por: Molina-Arcas, Miriam, et al.
Publicado: (2021) -
Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022) -
Targeting the “undruggable” RAS - new strategies - new hope?
por: Mörchen, Britta, et al.
Publicado: (2019) -
The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
por: Casalino, Laura, et al.
Publicado: (2022) -
Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets
por: Moon, Seonghyeon, et al.
Publicado: (2018)